Elevated Serum Levels of Carbohydrate Antigen 72-4 in Diabetic Kidney Disease

Exp Clin Endocrinol Diabetes. 2022 Jun;130(6):400-405. doi: 10.1055/a-1532-4576. Epub 2021 Oct 4.

Abstract

The aim of this study was to determine whether carbohydrate antigen 72-4 (CA72-4) is elevated in diabetic kidney disease (DKD), and examine the association between urinary albumin-to-creatinine ratio (UACR) and CA72-4 in patients with type 2 diabetes mellitus (T2DM). Non-dialysis patients with T2DM (n=296) and 90 healthy controls were recruited in this study. CA72-4 level was measured by electrochemiluminescence immunoassay. DKD was defined as UACR≥ 30 mg/g in the absence of a urinary infection or other renal diseases. We found that patients with DKD had significantly higher serum CA72-4 levels compared to those with normoalbuminuria and healthy controls. Positive rates of CA72-4 increased gradually and markedly from normoalbuminuria to microalbuminuria and to macroalbuminuria in diabetic patients (7.5, 11.2, and 17.4%, respectively; P for trend< 0.05). CA72-4 also showed a positive correlation with UACR (r=0.288, P< 0.01). Logistic regression analysis revealed the association of increased UACR with an increased odds ratio of elevation of CA72-4 levels (P for trend< 0.05) after multivariable adjustment. In conclusion, serum levels of CA72-4 increase abnormally with the increase in urinary albumin excretion, which affects the specificity of diagnosis of malignancies. An appropriate interpretation of CA72-4 is essential to prevent unnecessary and even hazardous diagnostic procedures in patients with T2DM.

MeSH terms

  • Albumins
  • Albuminuria / urine
  • Antigens, Tumor-Associated, Carbohydrate
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetic Nephropathies*
  • Humans

Substances

  • Albumins
  • Antigens, Tumor-Associated, Carbohydrate
  • CA-72-4 antigen